TY - JOUR
T1 - Involvement of Rac in thromboxane a2-induced human platelet activation
T2 - Regulation of sCD40 ligand release and PDGF-AB secretion
AU - Kageyama, Yasunari
AU - Tomoaki, D. O.I.
AU - Matsushima-Nishiwaki, Rie
AU - Iida, Yuko
AU - Akamatsu, Shigeru
AU - Kondo, Akira
AU - Kuroyanagi, Gen
AU - Yamamoto, Naohiro
AU - Mizutani, Jun
AU - Otsuka, Takanobu
AU - Tokuda, Haruhiko
AU - Iida, Hiroki
AU - Kozawa, Osamu
AU - Ogura, Shinji
PY - 2014/7
Y1 - 2014/7
N2 - We have previously shown that glycoprotein Ib/IX/V activation stimulates the release of the soluble CD40 ligand (sCD40L) via the generation of thromboxane A2 from human platelets. In the present study, the role of Rac, which is a member of the Rho family, was investigated in the thromboxane A2-stimulated release of platelet-derived growth factor (PDGF)-AB and sCD40L in human platelets. U46619, a thromboxane receptor agonist, stimulated the activation of Rac time-dependently in human platelets, and NSC23766, a selective inhibitor of the Rac-guanine nucleotide exchange factor interaction, reduced the U46619-induced platelet aggregation. NSC23766 markedly suppressed the U46619-induced p38 mitogen-activated protein (MAP) kinase phosphorylation. The thromboxane A2-induced release of PDGF-AB and sCD40L was significantly suppressed by NSC23766 in a dose-dependent manner. In addition, NSC23766 reduced the sCD40L release stimulated by ristocetin, a glycoprotein Ib/IX/V activator. These results indicate that Rac regulates the thromboxane A2-induced stimulation of PDGF-AB secretion and sCD40L release via the p38 MAP kinase in human platelets.
AB - We have previously shown that glycoprotein Ib/IX/V activation stimulates the release of the soluble CD40 ligand (sCD40L) via the generation of thromboxane A2 from human platelets. In the present study, the role of Rac, which is a member of the Rho family, was investigated in the thromboxane A2-stimulated release of platelet-derived growth factor (PDGF)-AB and sCD40L in human platelets. U46619, a thromboxane receptor agonist, stimulated the activation of Rac time-dependently in human platelets, and NSC23766, a selective inhibitor of the Rac-guanine nucleotide exchange factor interaction, reduced the U46619-induced platelet aggregation. NSC23766 markedly suppressed the U46619-induced p38 mitogen-activated protein (MAP) kinase phosphorylation. The thromboxane A2-induced release of PDGF-AB and sCD40L was significantly suppressed by NSC23766 in a dose-dependent manner. In addition, NSC23766 reduced the sCD40L release stimulated by ristocetin, a glycoprotein Ib/IX/V activator. These results indicate that Rac regulates the thromboxane A2-induced stimulation of PDGF-AB secretion and sCD40L release via the p38 MAP kinase in human platelets.
KW - P38 MAP kinase
KW - PDGF-AB
KW - Rac
KW - SCD40L
UR - http://www.scopus.com/inward/record.url?scp=84901396897&partnerID=8YFLogxK
U2 - 10.3892/mmr.2014.2143
DO - 10.3892/mmr.2014.2143
M3 - 学術論文
C2 - 24737161
AN - SCOPUS:84901396897
SN - 1791-2997
VL - 10
SP - 107
EP - 112
JO - Molecular Medicine Reports
JF - Molecular Medicine Reports
IS - 1
ER -